Working… Menu

A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02124148
Recruitment Status : Completed
First Posted : April 28, 2014
Last Update Posted : April 1, 2020
Information provided by (Responsible Party):
Eli Lilly and Company